FTC Releases Second Interim Staff Report on Prescription Drug …
4 days ago · The Big 3 PBMs netted such significant revenues all while patient, employer, and other health care plan sponsor payments for drugs steadily increased annually, according to the staff report. “The FTC staff’s second interim report finds that the three major pharmacy benefit managers hiked costs for a wide range of lifesaving drugs, including ...
FTC Releases Interim Staff Report on Prescription Drug Middlemen
The Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
PBMs made billions marking up specialty drugs by more than …
4 days ago · The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through ...
This Interim Report is part of an ongoing study by the Federal Trade Commission (“FTC” or the “Commission”) of pharmacy benefit managers (“PBMs”) and their impact on access to and affordability of medicines.
Healthcare Leaders Support FTC's Second Report on PBMs, While PBMs …
4 days ago · The new report is the latest development in a battle that has been brewing between the FTC and the PBMs. The agency released its first interim staff report on PBMs in July, which detailed how ...
FTC alleges PBMs cost consumers $7.3 billion marking up drug …
4 days ago · The Federal Trade Commission (FTC) released a 60-page report Tuesday targeting the three biggest pharmacy benefit managers (PBMs), claiming the companies hiked the prices of specialty drugs by ...
FTC: Big 3 PBMs generated $7.3B from specialty generic markups
4 days ago · The FTC’s findings—which analyzed 51 specialty generic drugs from 2017 to 2022—showed these pharmacy benefit managers’ (PBMs') affiliated pharmacies spun up $7.3 billion in excess revenue ...
FTC Report: PBMs May Benefit off Inflated Drug Prices - AARP
Jul 11, 2024 · An interim report released July 9 by the FTC highlights the “enormous power” third party players, known as pharmacy benefit managers (PBMs), have over prescription drug access and affordability in the U.S.
FTC report: Pharmacy benefit managers profit at expense of ... - CNN
Jul 9, 2024 · Pharmacy benefit managers, which negotiate the terms for prescription drug access for hundreds of millions of Americans, are racking up profits while squeezing patients and independent...
New FTC Report on PBMs Shows Wild Profiteering and Self …
Jul 9, 2024 · This second interim staff report on PBMs builds on the FTC’s first report, which was released July 9, 2024. During its ongoing inquiry into PBMs launched in 2022, the FTC received more than 24,000 comments from the public – including independent pharmacists – about anticompetitive contracts and how PBM practices affect consumers.